Retrospective Independent Safety Review of Closed Irrisept Study

NACompletedINTERVENTIONAL
Enrollment

592

Participants

Timeline

Start Date

March 31, 2020

Primary Completion Date

November 29, 2021

Study Completion Date

November 29, 2021

Conditions
Adverse Events
Interventions
DEVICE

Irrisept

"Irrisept® is a manual, self-contained irrigation device designed for wound cleansing and irrigation. The solution is 0.05% Chlorhexidine Gluconate (CHG) in sterile water for irrigation, USP (99.95%). Irrisept contents include the solution, a 450 mL bottle, and the Irriprobe applicator. Irrisept is a manual, self-contained irrigation device that can produce 7-8 psi of pressure for effective wound cleansing and irrigation. The user squeezes the bottle to create streams of solution and directs the fluid from the applicator onto a wound. The mechanical action of the streams of fluid being applied over a wound removes particulates and debris.~Subjects randomized to Irrisept on study protocol IRR-CT-901-2013-01 used the device, per the provided Instructions for Use. Those randomized to SoC received routine care, per the discretion of the investigator, and in accordance with the institution's guidelines."

DEVICE

Standard of Care

"Subjects randomized to SoC on study protocol IRR-CT-901-2013-01 used any SoC type, per the investigator's discretion. SoC types were not standardized. Sites recorded SoC information as free text. The following were recorded as SoC types: Saline (recorded as normal, warm and/or sterile saline or saline solution); Sodium Chloride (recorded as sodium chloride (NACL) or NACL 0.9%); SoC; Irrisept (recorded as normal saline \& Irrisept and Irrisept); Chloraprep; Gentamicin \& saline; unknown; and none."

Trial Locations (17)

21201

University of Maryland, Baltimore

33606

Tampa General Hospital University of South Florida (USF) College of Medicine, Tampa

38103

University of Tennessee Health Science Center, Memphis

40536

University of Kentucky Department of Surgery, Lexington

44109

MetroHealth Medical Center, Cleveland

45267

University of Cincinnati Division of Trauma/Critical Care Department of Surgery, Cincinnati

52242

University of Iowa Department of Surgery - 1504 JCP, Iowa City

53226

Medical College of Wisconsin Division of Trauma & Acute Care Surgery, Milwaukee

63110

St. Louis University Department of Surgery, St Louis

75390

University of Texas Southwestern (UTSW) Medical Center, Dallas

77030

University of Texas Health Science Center (UTHSC) at Houston Center for Translational Injury Research, Houston

78229

The University of Texas Health Center at San Antonio Division of Trauma and Emergency Surgery, San Antonio

80203

Denver Health Medical Center, Denver

85724

University of Arizona Department of Surgery, Tucson

90033

Los Angeles County & USC Medical Center, Los Angeles

98104

University of Washington Harborview Medical Center Department of Surgery, Seattle

01199

Baystate Medical Center Surgery Research, S3613, Springfield

Sponsors
All Listed Sponsors
lead

Irrimax Corporation

INDUSTRY

NCT05359666 - Retrospective Independent Safety Review of Closed Irrisept Study | Biotech Hunter | Biotech Hunter